Eli Lilly joins up with Camurus to make long-acting versions of the pharma's obesity and diabetes drugs, joining the industry ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Several GLP-1 medications, including Wegovy, list many side effects ... GLP-1 agonists are approved for people with type 2 diabetes to manage their blood sugar levels, and some are approved ...